Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease.

Dey-Rao R, Smith JR, Chow S, Sinha AA.

Genomics. 2014 Aug;104(2):144-55. doi: 10.1016/j.ygeno.2014.06.003. Epub 2014 Jun 21.

PMID:
24956118
[PubMed - in process]
2.

Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation.

Dey-Rao R, Sinha AA.

Genomics. 2014 Nov 18. pii: S0888-7543(14)00228-6. doi: 10.1016/j.ygeno.2014.11.004. [Epub ahead of print]

PMID:
25451738
[PubMed - as supplied by publisher]
3.

Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.

Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C.

Br J Dermatol. 2010 Jan;162(1):91-101. doi: 10.1111/j.1365-2133.2009.09472.x. Epub 2009 Sep 28.

PMID:
19785596
[PubMed - indexed for MEDLINE]
4.

Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus.

Furukawa F, Tokura Y, Matsushita K, Iwasaki-Inuzuka K, Onagi-Suzuki K, Yagi H, Wakita H, Takigawa M.

J Dermatol. 1996 Oct;23(10):670-6.

PMID:
8973031
[PubMed - indexed for MEDLINE]
5.

Cutaneous lupus erythematosus: An update.

Grönhagen CM, Nyberg F.

Indian Dermatol Online J. 2014 Jan;5(1):7-13. doi: 10.4103/2229-5178.126020. Review.

PMID:
24616847
[PubMed]
Free PMC Article
6.

Mucosal involvement in systemic and chronic cutaneous lupus erythematosus.

Burge SM, Frith PA, Juniper RP, Wojnarowska F.

Br J Dermatol. 1989 Dec;121(6):727-41.

PMID:
2611124
[PubMed - indexed for MEDLINE]
7.

Cutaneous lupus erythematosus: issues in diagnosis and treatment.

Walling HW, Sontheimer RD.

Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000. Review.

PMID:
19824738
[PubMed - indexed for MEDLINE]
8.

Using cDNA microarrays to identify human CD19(+) B cell gene products (ESTs) originated from systemic lupus erythematosus susceptibility loci.

Trevisan GL, Rassi DM, Baião AM, Sandrin-Garcia P, Mello SS, Tamia-Ferreira MC, Junta CM, Fachin AL, Marques MM, Sakamoto-Hojo ET, Donadi EA, Passos GA.

Autoimmun Rev. 2006 May;5(5):319-23. Epub 2006 Jan 6. Review.

PMID:
16782556
[PubMed - indexed for MEDLINE]
9.

The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience.

Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P.

Lupus. 2000;9(6):417-23.

PMID:
10981645
[PubMed - indexed for MEDLINE]
10.

Classification of lupus erythematosus based upon Japanese patients.

Tsuchida T.

Autoimmun Rev. 2009 May;8(6):453-5. doi: 10.1016/j.autrev.2008.12.017. Epub 2009 Jan 20.

PMID:
19162249
[PubMed - indexed for MEDLINE]
11.

A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap.

Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM, Chung SA, Graham RR, Zidovetzki R, Kelly JA, Kaufman KM, Jacob CO, Vyse TJ, Tsao BP, Kimberly RP, Gaffney PM, Alarcón-Riquelme ME, Harley JB, Langefeld CD; International Consortium on the Genetics of Systemic Erythematosus.

PLoS Genet. 2011 Dec;7(12):e1002406. doi: 10.1371/journal.pgen.1002406. Epub 2011 Dec 8.

PMID:
22174698
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus.

Beutner EH, Blaszczyk M, Jablonska S, Chorzelski TP, White D, Wolska H, Davis B.

Int J Dermatol. 1993 Sep;32(9):645-51.

PMID:
8407091
[PubMed - indexed for MEDLINE]
13.

Clinical manifestations of cutaneous lupus erythematosus.

Kuhn A, Sticherling M, Bonsmann G.

J Dtsch Dermatol Ges. 2007 Dec;5(12):1124-37. English, German.

PMID:
18042093
[PubMed - indexed for MEDLINE]
14.

Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.

Järvinen TM, Kanninen P, Jeskanen L, Koskenmies S, Panelius J, Hasan T, Ranki A, Saarialho-Kere U.

Br J Dermatol. 2007 Nov;157(5):970-80. Epub 2007 Sep 13.

PMID:
17854363
[PubMed - indexed for MEDLINE]
15.

Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.

Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Koskinen LL, Jeskanen L, Berglind L, Panelius J, Hasan T, Ranki A, Kere J, Saarialho-Kere U.

Exp Dermatol. 2010 Feb;19(2):123-31. doi: 10.1111/j.1600-0625.2009.00982.x. Epub 2009 Sep 16.

PMID:
19758313
[PubMed - indexed for MEDLINE]
Free Article
16.

Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center.

Kole AK, Ghosh A.

Indian J Dermatol. 2009;54(2):132-6. doi: 10.4103/0019-5154.53189.

PMID:
20101308
[PubMed]
Free PMC Article
17.

Cutaneous manifestations of systemic lupus erythematosus.

Yell JA, Mbuagbaw J, Burge SM.

Br J Dermatol. 1996 Sep;135(3):355-62.

PMID:
8949425
[PubMed - indexed for MEDLINE]
18.

Apoptosis in different cutaneous manifestations of lupus erythematosus.

Baima B, Sticherling M.

Br J Dermatol. 2001 May;144(5):958-66.

PMID:
11359381
[PubMed - indexed for MEDLINE]
19.

Accumulation of gamma delta T cells in chronic cutaneous lupus erythematosus.

Volc-Platzer B, Anegg B, Milota S, Pickl W, Fischer G.

J Invest Dermatol. 1993 Jan;100(1):84S-91S.

PMID:
8423404
[PubMed - indexed for MEDLINE]
20.

Activation/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus.

Alahlafi A, Wordsworth P, Wojnarowska F.

J Cutan Pathol. 2005 Sep;32(8):537-40.

PMID:
16115051
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk